Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $68.8M
Liabilities Breakdown FY2016
Total Liabilities: $27.4M
Asset Breakdown
Total Assets: $68.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $51.5M | 75.0% |
| Accounts Receivable | $9.9M | 14.3% |
| Inventory | $2.3M | 3.4% |
| Property, Plant & Equipment | $205.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.8M | 7.0% |
Liabilities Breakdown
Total Liabilities: $27.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 8.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.1M | 91.6% |